phosphatidylcholines has been researched along with 10-hydroxycamptothecin in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (10-hydroxycamptothecin) | Trials (10-hydroxycamptothecin) | Recent Studies (post-2010) (10-hydroxycamptothecin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 326 | 3 | 178 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | 10-hydroxycamptothecin (IC50) |
|---|---|---|---|
| DNA topoisomerase 1 | Homo sapiens (human) | 0.11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P; Lin, Y; Ran, H; Ren, J; Tan, J; Wang, Z; Zhang, Q; Zheng, Y | 1 |
1 other study(ies) available for phosphatidylcholines and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Male; Mice; Microbubbles; Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sonication; Tumor Burden | 2012 |